I am/have/had
I am looking for
Advanced Filters
Found 197 clinical trials
Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma
This is an open-label, single-center, Phase II trial designed to estimate in terms of PFS the efficacy of cabozantinib, given as second- or third- line treatment in HCC patients that progress on or are intolerant to immune checkpoint inhibitors, including anti-PD-1 and anti-PD-L1 antibodies.
hepatocellular carcinoma
radiofrequency ablation
pd-l1
hepatitis
TACE
- 0 views
- 19 Feb, 2024
- 1 location
Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma
The aie of this clinical study is the safety and efficacy of combination therapy for HCC patients.
serum bilirubin level
combined modality therapy
systemic therapy
hepatocellular carcinoma
targeted therapy
- 0 views
- 19 Feb, 2024
- 1 location